Bristol's $1 billion Bavarian deal may signal cancer vaccine revival

LONDON (Reuters) - The idea of using vaccines to fight cancer has received a shot in the arm from a $1 billion deal between Bristol-Myers Squibb and Bavarian Nordic.

via Reuters: Health News Read More Here..